Bionik Laboratories Statistics
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
BNKL has 12.59 million shares outstanding.
| Current Share Class | 12.48M |
| Shares Outstanding | 12.59M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +1.40% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | -0.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.20
| Current Ratio | 1.20 |
| Quick Ratio | 0.38 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.71 |
| Interest Coverage | -44.55 |
Financial Efficiency
Return on equity (ROE) is -768.84% and return on invested capital (ROIC) is -161.30%.
| Return on Equity (ROE) | -768.84% |
| Return on Assets (ROA) | -74.23% |
| Return on Invested Capital (ROIC) | -161.30% |
| Return on Capital Employed (ROCE) | -453.30% |
| Revenue Per Employee | 150,434 |
| Profits Per Employee | -412,169 |
| Employee Count | 12 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 0.42 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 13.83 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 98.47 |
| Average Volume (20 Days) | 24 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.09 |
Income Statement
In the last 12 months, BNKL had revenue of 1.81 million and -4.95 million in losses. Loss per share was -0.72.
| Revenue | 1.81M |
| Gross Profit | 989,877 |
| Operating Income | -4.77M |
| Pretax Income | -4.95M |
| Net Income | -4.95M |
| EBITDA | -4.71M |
| EBIT | -4.77M |
| Loss Per Share | -0.72 |
Balance Sheet
The company has 427,383 in cash and 2.41 million in debt, giving a net cash position of -1.98 million or -0.16 per share.
| Cash & Cash Equivalents | 427,383 |
| Total Debt | 2.41M |
| Net Cash | -1.98M |
| Net Cash Per Share | -0.16 |
| Equity (Book Value) | -1.64M |
| Book Value Per Share | -0.23 |
| Working Capital | 468,377 |
Cash Flow
In the last 12 months, operating cash flow was -3.39 million and capital expenditures -8,694, giving a free cash flow of -3.40 million.
| Operating Cash Flow | -3.39M |
| Capital Expenditures | -8,694 |
| Free Cash Flow | -3.40M |
| FCF Per Share | -0.27 |
Margins
Gross margin is 54.83%, with operating and profit margins of -264.40% and -273.99%.
| Gross Margin | 54.83% |
| Operating Margin | -264.40% |
| Pretax Margin | -273.99% |
| Profit Margin | -273.99% |
| EBITDA Margin | -260.91% |
| EBIT Margin | -264.40% |
| FCF Margin | n/a |
Dividends & Yields
BNKL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.13% |
| Shareholder Yield | -18.13% |
| Earnings Yield | -392,853.38% |
| FCF Yield | -269,738.52% |
Stock Splits
The last stock split was on October 30, 2018. It was a reverse split with a ratio of 0.006666.
| Last Split Date | Oct 30, 2018 |
| Split Type | Reverse |
| Split Ratio | 0.006666 |
Scores
BNKL has an Altman Z-Score of -45.28. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -45.28 |
| Piotroski F-Score | n/a |